<?xml version='1.0' encoding='utf-8'?>
<document id="24700822"><sentence text="Application of chimeric mice with humanized liver for study of human-specific drug metabolism." /><sentence text="Human-specific or disproportionately abundant human metabolites of drug candidates that are not adequately formed and qualified in preclinical safety assessment species pose an important drug development challenge" /><sentence text=" Furthermore, the overall metabolic profile of drug candidates in humans is an important determinant of their drug-drug interaction susceptibility" /><sentence text=" These risks can be effectively assessed and/or mitigated if human metabolic profile of the drug candidate could reliably be determined in early development" /><sentence text=" However, currently available in vitro human models (e" /><sentence text="g" /><sentence text=", liver microsomes, hepatocytes) are often inadequate in this regard" /><sentence text=" Furthermore, the conduct of definitive radiolabeled human ADME studies is an expensive and time-consuming endeavor that is more suited for later in development when the risk of failure has been reduced" /><sentence text=" We evaluated a recently developed chimeric mouse model with humanized liver on uPA/SCID background for its ability to predict human disposition of four model drugs (lamotrigine, diclofenac, MRK-A, and propafenone) that are known to exhibit human-specific metabolism"><entity charOffset="166-177" id="DDI-PubMed.24700822.s9.e0" text="lamotrigine" /><entity charOffset="179-189" id="DDI-PubMed.24700822.s9.e1" text="diclofenac" /><entity charOffset="191-196" id="DDI-PubMed.24700822.s9.e2" text="MRK-A" /><entity charOffset="202-213" id="DDI-PubMed.24700822.s9.e3" text="propafenone" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e0" e2="DDI-PubMed.24700822.s9.e0" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e0" e2="DDI-PubMed.24700822.s9.e1" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e0" e2="DDI-PubMed.24700822.s9.e2" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e0" e2="DDI-PubMed.24700822.s9.e3" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e1" e2="DDI-PubMed.24700822.s9.e1" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e1" e2="DDI-PubMed.24700822.s9.e2" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e1" e2="DDI-PubMed.24700822.s9.e3" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e2" e2="DDI-PubMed.24700822.s9.e2" /><pair ddi="false" e1="DDI-PubMed.24700822.s9.e2" e2="DDI-PubMed.24700822.s9.e3" /></sentence><sentence text=" The results from these studies demonstrate that chimeric mice were able to reproduce the human-specific metabolite profile for lamotrigine, diclofenac, and MRK-A"><entity charOffset="128-139" id="DDI-PubMed.24700822.s10.e0" text="lamotrigine" /><entity charOffset="141-151" id="DDI-PubMed.24700822.s10.e1" text="diclofenac" /><entity charOffset="157-166" id="DDI-PubMed.24700822.s10.e2" text="MRK-A" /><pair ddi="false" e1="DDI-PubMed.24700822.s10.e0" e2="DDI-PubMed.24700822.s10.e0" /><pair ddi="false" e1="DDI-PubMed.24700822.s10.e0" e2="DDI-PubMed.24700822.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24700822.s10.e0" e2="DDI-PubMed.24700822.s10.e2" /><pair ddi="false" e1="DDI-PubMed.24700822.s10.e1" e2="DDI-PubMed.24700822.s10.e1" /><pair ddi="false" e1="DDI-PubMed.24700822.s10.e1" e2="DDI-PubMed.24700822.s10.e2" /></sentence><sentence text=" In the case of propafenone, however, the human-specific metabolism was not detected as a predominant pathway, and the metabolite profiles in native and humanized mice were similar; this was attributed to the presence of residual highly active propafenone-metabolizing mouse enzymes in chimeric mice"><entity charOffset="16-27" id="DDI-PubMed.24700822.s11.e0" text="propafenone" /><entity charOffset="244-255" id="DDI-PubMed.24700822.s11.e1" text="propafenone" /><pair ddi="false" e1="DDI-PubMed.24700822.s11.e0" e2="DDI-PubMed.24700822.s11.e0" /><pair ddi="false" e1="DDI-PubMed.24700822.s11.e0" e2="DDI-PubMed.24700822.s11.e1" /></sentence><sentence text=" Overall, the data indicate that the chimeric mice with humanized liver have the potential to be a useful tool for the prediction of human-specific metabolism of xenobiotics and warrant further investigation" /><sentence text=" " /></document>